https://www.marketscreener.com/quote/stock/ASTRAZENECA-PLC-4000930/news/AstraZeneca-Imfinzi-plus-tremelimumab-demonstrated-unprecedented-survival-in-1st-line-unresectable-37579971/?utm_source=telegram&utm_medium=social&utm_campaign=share